Acquiring Company
Ginkgo Bioworks
Acquired Company
Ginkgo Biosecurity
BostonBostonOtherManufacturingBiotechnologySustainabilitySoftwareScience And EngineeringBiotechnologyHealth CareDescription
On February 26, 2026, Ginkgo Bioworks Holdings, Inc. announced the acquisition of Ginkgo Biosecurity, LLC through its wholly owned subsidiary, Ginkgo Bioworks, Inc. This acquisition involves the transfer of equity interests constituting most of the company's Biosecurity segment operations. The transaction is expected to enhance Ginkgo's capabilities in biosecurity solutions.
Who to call at Ginkgo Bioworks, and when
When Ginkgo Bioworks changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Ginkgo Bioworks raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ginkgo Bioworks, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ginkgo Bioworks. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ginkgo Bioworks makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Ginkgo Biosecurity?
Ginkgo Biosecurity was acquired by Ginkgo Bioworks, based in Boston. The deal was reported on February 27, 2026. Ginkgo Bioworks is publicly traded (DNA) and operates in Other.
When did Ginkgo Bioworks acquire Ginkgo Biosecurity?
Ginkgo Bioworks's acquisition of Ginkgo Biosecurity was reported on February 27, 2026. On February 26, 2026, Ginkgo Bioworks Holdings, Inc. announced the acquisition of Ginkgo Biosecurity, LLC through its wholly owned subsidiary, Ginkgo Bioworks, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ginkgo Biosecurity do?
Ginkgo Biosecurity, LLC is a subsidiary of Ginkgo Bioworks focused on biosecurity solutions. The company leverages synthetic biology technology to develop advanced measures against biological threats. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.